As reported by allsci, China’s National Medical Products Administration (NMPA) has granted conditional approval to TransThera Sciences’ Yochanra (tinengotinib) for adults with unresectable, advanced, or
As reported by PharmaBiz, Zydus Lifesciences has announced the launch of Revahale (revefenacin), a once-daily nebulized long-acting muscarinic antagonist (LAMA) for the maintenance treatment of
What Happened? Hansa Biopharma, a Swedish company, announced that the first patient in Australia has successfully received a kidney transplant after being treated with a
As reported on BioSpace, AstraZeneca has discontinued a pivotal Phase 3 trial evaluating its investigational bispecific antibody volrustomig in advanced non-small cell lung cancer (NSCLC)
New observational research suggests that addressing obesity alongside inflammatory joint disease could improve treatment outcomes for people with psoriatic arthritis (PsA). As reported on MedIndia,
As reported on News Medical, researchers are highlighting a new class of therapies that could improve outcomes for people living with primary biliary cholangitis (PBC),
Researchers at MIT have identified a potential new approach to reducing lung cancer risk by targeting caspase-1, an enzyme involved in inflammation. Findings published in
A recent study shared by The Lancet shows that a first-in-class investigational therapy targeting neurotrophin-3 (NT-3) significantly reduced pain and improved function in patients with
As reported by the ICIJ, the FDA originally approved Keytruda (pembrolizumab) combined with cisplatin and gemcitabine on October 31, 2023, to treat locally advanced inoperable
Editor’s Note: Patient Worthy is honored to present this article, originally written by Camille Johnson. People living with chronic illness or long-term treatment plans often
Editor’s Note: Patient Worthy is honored to share this article with you, kindly provided to us by our friends at End Sepsis. To see the
If you had asked me a few years ago what I thought my biggest health concern would be, lung cancer wouldn’t have even crossed my
Reflections on V122I, Genetic Risk, and the Questions Black Families Are Still Asking Editor’s Note: This article was written and submitted to us by Erin
According to recent reports, assistant pediatric professor at the Boston Children’s Hospital, Prof. Meenakshi Rao, noted that infections associated with Clostridioides difficile (C. Diff.) are difficult to eradicate. Nonetheless,
For more than 20 years, I had a treatment routine that worked. My specialty pharmacy delivered the medications I needed and coordinated trained nurses who
The Ebola outbreak in DR Congo was declared in May 2026. It is now the second worst on record with estimates that the death toll
As shared on GlobeNewswire, a biotechnology company called ABLi Therapeutics has released encouraging findings from a research study on a potential new Parkinson’s treatment called
As reported on Fierce Biotech, Samsung Electronics has obtained clearance from the U.S. Food and Drug Administration (FDA) for software features that transform select Galaxy
This Autoinflammatory Awareness Month, we’re standing with those living with autoinflammatory diseases and the people who support them. Share this post to help spread awareness and remind this community that they are seen and supported.
#AutoinflammatoryAwarenessMonth #AutoinflammatoryDisease #PatientAdvocacy #PatientWorthy
#disability"The U.S. Mint has released a new quarter honoring the late disability justice activist Stacey Park Milbern, marking the first time a woman in a wheelchair -- and the first Korean American -- has been featured on U.S. currency.
Born with congenital muscular dystrophy, Stacey was one of the pioneers of the disability justice movement and helped to pass a law in North Carolina requiring disability history education. Stacey passed away on her 33rd birthday in 2020, but her legacy continues to inspire change and greater inclusion." - via Lean In
The American Women Quarters Program, which began in 2022, has honored a wide array of trailblazing American women across diverse fields including civil rights, science, arts, and government, featuring five new designs annually. The four-year program concludes in 2025 after producing 20 quarters total; in addition to Milbern, this year's honorees are Ida B. Wells, Juliette Gordon Low, Dr. Vera Rubin, and Althea Gibson. The program's coins have been the first to feature a Black woman, an LGBT person, a Hispanic American, an Asian American, a Jewish American, and a Native Hawaiian on U.S. currency.
To learn more or find coins, visit the US Mint's website at www.usmint.gov/coins/coin-programs/american-women-quarters-program/
For an inspiring picture book about a real-life Mighty Girl who fought for disability rights by crawling up the steps of the U.S. Capitol, we highly recommend "All The Way To The Top" for ages 5 to 9 at www.amightygirl.com/all-the-way-to-the-top
For kids' books about Judy Heumann, another leading disability rights activist who used a wheelchair, we recommend "Fighting for YES! The Story of Disability Rights Activist Judith Heumann" for ages 6 to 9 (www.amightygirl.com/fighting-for-yes) and "Rolling Warrior: The Incredible, Sometimes Awkward, True Story of a Girl on Wheels Who Helped Spark a Revolution" for ages 10 and up (www.amightygirl.com/rolling-warrior)
Judith Heumann was also the author of a powerful memoir for adult readers, "Being Heumann: An Unrepentant Memoir of a Disability Rights Activist" at www.amightygirl.com/being-heumann
For books for children and teens starring Mighty Girls with disabilities of all varieties, visit our blog post "Many Ways To Be Mighty: 35 Books Starring Mighty Girls with Disabilities" at www.amightygirl.com/blog?p=12992
Fabry Support & Information GroupGet the scoop: bit.ly/3SFxEPY
The Fabry Support & Information Group marks 30 years of advocacy as founder Jack Johnson transitions leadership to new director Lisa Bacon.
#FabryDisease #RareDisease #RareCommunity #FabryDiseaseNews #Bionews
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
